Table 4 Clinical outcomes of COVID-19 patients included in the study (n = 439)
From: Comorbidities and outcomes among patients hospitalized with COVID-19 in Upper Egypt
All patients (n = 439) | Patients without comorbidity (n = 168) | Patients with comorbidities (n = 271) | P-value | |
|---|---|---|---|---|
ICU admission | 124 (34.1%) | 28 (16.4%) | 96 (35.8%) | < 0.001 |
Oxygen therapy | ||||
No need | 130 (29.6%) | 76 (45.2%) | 54 (19.9%) | < 0.001 |
Simple face mask | 134 (30.5%) | 53 (31.5%) | 81 (29.9%) | |
Venturi mask | 45 (10.3%) | 14 (8.3%) | 31 (11.4%) | |
Non-rebreathing mask | 11 (2.5%) | 3 (1.8%) | 8 (3.0%) | |
Noninvasive MV | 17 (3.9%) | 4 (2.4%) | 13 (4.8%) | |
Invasive MV | 102 (23.2%) | 18 (10.7%) | 84 (31.0%) | |
Outcomea | ||||
Cured/improved | 296 (67.4%) | 136 (81%) | 160 (59%) | < 0.001 |
Died | 94 (21.4%) | 17 (10.1%) | 77 (28.4%) | |
Duration of hospital stay | 8.4 ± 6.1 | 8.5 ± 6.1 | 8.4 ± 6.0 | 0.853 |